Relief Therapeutics, a biopharmaceutical company, has launched a Level 1 American Depositary Receipt (“ADR”) program in the United States. From 18 November 2021, ADRs can be traded over-the-counter. Relief’s ADR program complements the existing main listing of
Tags :Peter Kühn
Biopharmaceutical company Relief Theraputics Holding, has a binding agreement with two institutional U.S. investors completed. The contract provides for the purchase of Relief shares with a total value of CHF 15 million, which come from
Relief Therapeutics Holding, a biopharmaceutical company seeking to provide patients therapeutic relief from serious diseases with high unmet need, has issued 1,000,000,000 additional registered shares out of the authorised share capital approved by the Annual
H.C. Wainwright acted as sole placement agent in connection to the private placement of 71,428,572 shares in Relief Therapeutics Holding, a Swiss biopharmaceutical company listed at SIX Swiss Exchange, at a price of CHF 0.21 per
International hotel group Meininger manages its successful market entry in Switzerland and opens new hotels in Zürich Greencity (174 rooms, 582 beds) and Genève Centre Charmilles (104 rooms, 362 beds). Vischer advises Meininger on any Swiss
The VISCHER team led by partner Dr. Adrian Dörig (Corporate Finance - pictured) included Dr. Peter Kühn (Counsel, Corporate / M & A), Flavio Langenegger (Associate, Corporate / M & A), Florian Kambor (Junior Associate, Corporate / M&
The Pestalozzi team included Christian Leuenberger (Lead Partner - Capital Markets, Corporate/M&A - pictured), Severin Roelli (Partner - Corpoarte/M&A), Manu Ferro (Associate - Banking & Finance).
VISCHER advised MCAM as lead counsel. The team was led by partner Felix W. Egli (Corporate/M&A - pictured) and included partner Christoph Niederer (Tax), managing associate Thomas Steiner-Krizaj (Corporate/M&A) , counsel Peter
The team, led by partner Adrian Dörig (Corporate Finance - pictured) included Peter Kühn (Counsel, Corporate / M&A), Michel Stübi and Florian Angstmann (Associates, Corporate / M&A), Aleksandra Simic (Junior Associate, Corporate /
The VISCHER team, led by partner Robert Bernet (Corporate / M & A - pictured) includes Peter Kühn (Counsel, Corporate / M & A), Florian Kambor (Junior Associate, Corporate / M & A) and Christian Wyss (Partner, IP).
